Why Enterprise Deals Stall After Positive Buyer Feedback: A Working Guide

Enterprise deals rarely die because the buyer disliked the product. They stall because the economic buyer, the risk function, or a quiet veto player never bought in, and the enthusiastic contact you were speaking to had neither the authority nor the political capital to carry the decision alone. If your pipeline is full of warm feedback and cold outcomes, the problem is almost always in the account, not in the pitch.

What a Stall Actually Is

A stall is not silence. It is the moment the deal moves from your sponsor's desk into the wider organisation and loses energy. In regulated firms, that transition almost always involves second line risk, information security, procurement, legal, and often a divisional CFO. Each of these functions has veto power, a backlog, and no incentive to move quickly.

The sponsor's enthusiasm, which felt like momentum, now looks to them like one person's preference competing with twenty other initiatives. If you have not given the sponsor the material and the air cover to defend the case internally, the deal does not get rejected. It gets deprioritised, which looks identical from the outside.

The Four Common Causes, in Order of Frequency

1. The sponsor was coachable but not powerful

You spent months with a director who loved the solution. They are not on the investment committee. They cannot get a slot on the CFO's agenda. Their boss has a different priority this quarter. Positive feedback from this person was genuine and worthless at the same time.

2. Risk and compliance surfaced late

In banks, insurers and asset managers, second line review is not a formality. If your first substantive conversation with risk happens after commercial terms are drafted, you have already lost three months. Worse, risk will often raise questions the sponsor cannot answer, and the sponsor will go quiet rather than come back to you looking uninformed.

3. The business case did not survive translation

Your sponsor understood the value. When they wrote the paper for the exec committee, half of it was lost. The ROI figures were challenged, the implementation risk was underestimated by the sponsor and overestimated by the committee, and no one in the room had the context to defend it.

4. A competing internal priority took the budget

The deal did not lose to a competitor. It lost to a regulatory remediation programme, a core system migration, or a cost-cutting mandate that landed in Q3. You will rarely be told this directly.

What To Actually Do

Map the decision before you celebrate feedback. After any positive meeting, ask the sponsor directly: who else needs to agree, who has killed similar initiatives before, and what is competing for the same budget line. If they cannot answer, that is your finding.

Engage risk and procurement early and on your own initiative. Offer to walk second line through the control model before the sponsor asks. This protects the sponsor and shortens the cycle. It also demonstrates that you understand how regulated firms actually make decisions.

Write the internal paper for your sponsor. Not literally, but close. Give them a one-page business case, a risk summary, and answers to the three questions their exec committee will ask. Assume the paper will be read by people who have never met you.

Run a structured diagnostic when a deal goes quiet. Do not chase with "just checking in" emails. Ask the sponsor for fifteen minutes to understand what changed internally. If they will not take the call, the deal is already lost and you need to know why for the next one.

The Next Decision

Look at your top five stalled deals. For each, write down the name of the economic buyer, the risk owner, and the competing priority. If you cannot fill in all three for most of them, the problem is not the market. It is that your qualification stops at the sponsor. Fix that before the next quarter closes.

Frequently Asked Questions

How long should we wait before declaring a stalled deal dead?

If you have had no substantive movement in two full buying cycles for that organisation, typically sixty to ninety days in financial services, treat it as lost and reopen it as a new pursuit with a different entry point.

Should we go around a sponsor who has gone quiet?

Rarely, and only with their knowledge. Going around a sponsor usually ends both the deal and the relationship. Better to ask the sponsor directly whether they still have the mandate, and offer to help them re-engage internally.

How do we tell genuine interest from polite interest?

Genuine interest produces introductions to other stakeholders, access to internal documents, and specific questions about implementation. Polite interest produces compliments and no follow-up actions.

What is the single most useful question to ask a sponsor after a good meeting?

"Who in your organisation would be most sceptical of this, and why?" The answer tells you where the deal will actually be decided.